{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T22:15:38Z","timestamp":1775600138121,"version":"3.50.1"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9]]},"abstract":"<jats:p>There is a large geographical variability in prostate cancer incidence and mortality trends, mostly because of heterogeneity in control efforts across regions. We aimed to describe the time trends in prostate cancer incidence and mortality in Portugal, overall and by region, and to estimate the number of incident cases and deaths in 2020. The number of cases and incidence rates in 1998\u20132009 were collected from the Regional Cancer Registries. The number of deaths and mortality rates were obtained from the WHO mortality database (1988\u20132003 and 2007\u20132013) and Statistics Portugal (2004\u20132006; 1991\u20132013 by region). JoinPoint analyses were used to identify significant changes in trends in age-standardized incidence and mortality rates. Incidence and mortality predictions for 2020 were performed using Poisson regression models and population projections provided by Statistics Portugal. In Portugal, prostate cancer incidence has been increasing since 1998 (1.8%\/year), with the exception of the North Region, with a decrease since 2006 (\u22123.2%\/year). An overall mortality decline has been observed since 1997 (\u22122.2%\/year), although there were two patterns of mortality variation at the regional level: one with an inflection point or significant variation in the rates and the other without significant variation. If these trends are maintained, \u223c8600 incident cases and 1700 deaths may be expected to occur in Portugal in 2020. Despite the overall increasing incidence and decreasing mortality, there is a large heterogeneity across regions. Future studies should address regional differences in the trends of prostate specific antigen screening and in the effective management of prostate cancer.<\/jats:p>","DOI":"10.1097\/cej.0000000000000285","type":"journal-article","created":{"date-parts":[[2016,8,18]],"date-time":"2016-08-18T16:05:08Z","timestamp":1471536308000},"page":"404-410","source":"Crossref","is-referenced-by-count":10,"title":["Prostate cancer incidence and mortality in Portugal: trends, projections and regional differences"],"prefix":"10.1097","volume":"26","author":[{"given":"Francisco","family":"Pina","sequence":"first","affiliation":[]},{"given":"Clara","family":"Castro","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Ferro","sequence":"additional","affiliation":[{"name":"ISPUP-EPIUnit, Universidade do Porto, Rua das Taipas, n135, 4050-600 Porto, Portugal"}]},{"given":"Maria J.","family":"Bento","sequence":"additional","affiliation":[{"name":"North Region Cancer Registry (RORENO) \u2013 Portuguese Oncology Institute"}]},{"given":"Nuno","family":"Lunet","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-20230901","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.eururo.2012.11.013","article-title":"Obesity and prostate cancer: weighing the evidence","volume":"63","author":"Allott","year":"2013","journal-title":"Eur Urol"},{"key":"R2-20230901","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/iju.12634","article-title":"Hospital admissions after transrectal ultrasound-guided biopsy of the prostate in men diagnosed with prostate cancer: a database analysis in England","volume":"22","author":"Anastasiadis","year":"2015","journal-title":"Int J Urol"},{"key":"R3-20230901","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.ejca.2013.09.002","article-title":"Recent trends in incidence of five common cancers in 26 European countries since 1988: analysis of the European Cancer Observatory","volume":"51","author":"Arnold","year":"2015","journal-title":"Eur J Cancer"},{"key":"R4-20230901","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.7314\/APJCP.2015.16.3.1259","article-title":"Geographic disparities in prostate cancer outcomes \u2013 review of international patterns","volume":"16","author":"Baade","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"R5-20230901","first-page":"499","article-title":"Trends in prostate cancer mortality in Portugal (1980\u20132006)","volume":"24","author":"Bastos","year":"2011","journal-title":"Acta Med Port"},{"key":"R6-20230901","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/ijc.29670","article-title":"Cancer incidence in five continents: inclusion criteria, highlights from volume X and the global status of cancer registration","volume":"137","author":"Bray","year":"2015","journal-title":"Int J Cancer"},{"key":"R7-20230901","article-title":"Cancer incidence predictions in the North of Portugal: keeping population-based cancer registration up to date","author":"Castro","year":"2015","journal-title":"Eur J Cancer Prev"},{"key":"R8-20230901","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.eururo.2012.02.054","article-title":"International variation in prostate cancer incidence and mortality rates","volume":"61","author":"Center","year":"2012","journal-title":"Eur Urol"},{"key":"R9-20230901","article-title":"Cancer screening in Portugal: sex differences in prevalence, awareness of organized programmes and perception of benefits and adverse effects","author":"Costa","year":"2016","journal-title":"Health Expect"},{"issue":"1\u20132","key":"R12-20230901","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000371717","article-title":"Changes in prognostic and therapeutic parameters in prostate cancer from an epidemiological view over 20 years","volume":"38","author":"D\u00f6rr","year":"2015","journal-title":"Oncol Res Treat"},{"key":"R13-20230901","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/1097-0258(20000715)19:13<1741::AID-SIM496>3.0.CO;2-O","article-title":"Comparison of different approaches to incidence prediction based on simple interpolation techniques","volume":"19","author":"Dyba","year":"2000","journal-title":"Stat Med"},{"key":"R15-20230901","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013b","journal-title":"Eur J Cancer"},{"key":"R16-20230901","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"R18-20230901","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaoncol.2015.0735","article-title":"The global burden of cancer 2013","volume":"1","author":"Fitzmaurice","year":"2015","journal-title":"JAMA Oncol"},{"key":"R17-20230901","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1038\/bjc.2013.217","article-title":"Model-based patterns in prostate cancer mortality worldwide","volume":"108","author":"Fontes","year":"2013","journal-title":"Br J Cancer"},{"key":"R19-20230901","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/sim.4780131503","article-title":"Precision of incidence predictions based on Poisson distributed observations","volume":"13","author":"Hakulinen","year":"1994","journal-title":"Stat Med"},{"key":"R20-20230901","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.eururo.2013.06.051","article-title":"Early detection of prostate cancer: European Association of Urology recommendation","volume":"64","author":"Heidenreich","year":"2013","journal-title":"Eur Urol"},{"key":"R21-20230901","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1158\/1055-9965.EPI-15-0723","article-title":"Trends in United States prostate cancer incidence rates by age and stage, 1995\u20132012","volume":"25","author":"Hoffman","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R22-20230901","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/gerona\/gls135","article-title":"The impact of PSA screening on prostate cancer mortality and overdiagnosis of prostate cancer in the United States","volume":"68","author":"Howrey","year":"2013","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R23-20230901","first-page":"CD004720","article-title":"Screening for prostate cancer","author":"Ilic","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R27-20230901","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1001\/jama.2015.14905","article-title":"Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations","volume":"314","author":"Jemal","year":"2015","journal-title":"JAMA"},{"key":"R28-20230901","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"R29-20230901","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.eururo.2013.12.062","article-title":"Overdiagnosis and overtreatment of prostate cancer","volume":"65","author":"Loeb","year":"2014","journal-title":"Eur Urol"},{"key":"R30-20230901","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/pcan.2013.34","article-title":"Statin use and incident prostate cancer risk: does the statin brand matter? A population-based cohort study","volume":"17","author":"Lustman","year":"2014","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"R31-20230901","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/annonc\/mdv001","article-title":"European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women?","volume":"26","author":"Malvezzi","year":"2015","journal-title":"Ann Oncol"},{"key":"R32-20230901","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/bjc.2011.430","article-title":"Cancer incidence in the United Kingdom: projections to the year 2030","volume":"105","author":"Mistry","year":"2011","journal-title":"Br J Cancer"},{"key":"R36-20230901","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.eururo.2013.05.030","article-title":"Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer","volume":"64","author":"Roobol","year":"2013","journal-title":"Eur Urol"},{"key":"R42-20230901","doi-asserted-by":"crossref","first-page":"e1644","DOI":"10.1097\/MD.0000000000001644","article-title":"Statin use reduces prostate cancer all-cause mortality: a nationwide population-based cohort study","volume":"94","author":"Sun","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"R44-20230901","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/ijc.29894","article-title":"Prostate cancer incidence in 43 populations worldwide: an analysis of time trends overall and by age group","volume":"138","author":"Zhou","year":"2016","journal-title":"Int J Cancer"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008469-201709000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:06:35Z","timestamp":1693613195000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008469-201709000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000285","relation":{},"ISSN":["0959-8278"],"issn-type":[{"value":"0959-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}